GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Geratherm Medical AG (XTER:GME) » Definitions » Cyclically Adjusted Revenue per Share

Geratherm Medical AG (XTER:GME) Cyclically Adjusted Revenue per Share : €0.00 (As of Jun. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Geratherm Medical AG Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Geratherm Medical AG's adjusted revenue per share for the three months ended in Jun. 2023 was €0.000. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €0.00 for the trailing ten years ended in Jun. 2023.

During the past 12 months, Geratherm Medical AG's average Cyclically Adjusted Revenue Growth Rate was -100.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 6.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 4.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Geratherm Medical AG was 6.90% per year. The lowest was 3.10% per year. And the median was 4.20% per year.

As of today (2024-06-07), Geratherm Medical AG's current stock price is €4.20. Geratherm Medical AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2023 was €0.00. Geratherm Medical AG's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Geratherm Medical AG was 3.42. The lowest was 0.97. And the median was 2.25.


Geratherm Medical AG Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Geratherm Medical AG's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Geratherm Medical AG Cyclically Adjusted Revenue per Share Chart

Geratherm Medical AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.13 4.22 4.37 4.67 5.16

Geratherm Medical AG Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.84 4.95 5.09 5.16 -

Competitive Comparison of Geratherm Medical AG's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Geratherm Medical AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Geratherm Medical AG's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Geratherm Medical AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Geratherm Medical AG's Cyclically Adjusted PS Ratio falls into.



Geratherm Medical AG Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Geratherm Medical AG's adjusted Revenue per Share data for the three months ended in Jun. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2023 (Change)*Current CPI (Jun. 2023)
=0/123.1404*123.1404
=0.000

Current CPI (Jun. 2023) = 123.1404.

Geratherm Medical AG Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201306 0.908 98.516 1.135
201309 1.239 98.983 1.541
201312 0.706 99.356 0.875
201403 0.837 99.543 1.035
201406 1.007 99.543 1.246
201409 1.112 99.823 1.372
201412 1.005 99.543 1.243
201503 1.119 99.717 1.382
201506 1.087 100.417 1.333
201509 1.128 100.417 1.383
201512 1.164 99.717 1.437
201603 1.189 100.017 1.464
201606 1.212 100.717 1.482
201609 0.991 101.017 1.208
201612 1.063 101.217 1.293
201703 1.276 101.417 1.549
201706 1.039 102.117 1.253
201709 1.003 102.717 1.202
201712 0.957 102.617 1.148
201803 1.068 102.917 1.278
201806 1.077 104.017 1.275
201809 1.091 104.718 1.283
201812 1.140 104.217 1.347
201903 1.318 104.217 1.557
201906 0.926 105.718 1.079
201909 0.960 106.018 1.115
201912 0.926 105.818 1.078
202003 1.342 105.718 1.563
202006 1.536 106.618 1.774
202009 1.219 105.818 1.419
202012 1.594 105.518 1.860
202103 1.464 107.518 1.677
202106 1.193 108.486 1.354
202109 1.141 109.435 1.284
202112 1.147 110.384 1.280
202203 1.356 113.968 1.465
202206 1.215 115.760 1.292
202209 0.969 118.818 1.004
202212 1.514 119.345 1.562
202306 0.000 123.140 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Geratherm Medical AG  (XTER:GME) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Geratherm Medical AG was 3.42. The lowest was 0.97. And the median was 2.25.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Geratherm Medical AG Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Geratherm Medical AG's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Geratherm Medical AG (XTER:GME) Business Description

Traded in Other Exchanges
Address
Fahrenheitstrasse 1, Geratal, DEU, 99331
Geratherm Medical AG is a Germany-based medical technology company. The firm operates through four segments: Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. Healthcare Diagnostic segment which generates majority revenue provides analog and digital products for measuring body temperature, blood pressure monitors and other products for measuring temperature, as well as related accessories. Medical Warming Systems offers solutions for temperature management at all stages in the pre-clinical and clinical care of the patients, such as rescue situations and operations. Cardio/Stroke segment comprises products for preventing strokes. The Respiratory segment focuses on the development and production of products for pulmonary functional diagnostics.
Executives
Dr. Gert Frank Supervisory Board
Christian Frick Board of Directors